OpenLegislation

The Misuse of Drugs (Amendment) (Revocation) (England, Wales and Scotland) Regulations 2022

S.I. 2022/559 · Made 17 May 2022

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Dangerous Drugs

Made 17th May 2022

Laid before Parliament 23rd May 2022

Coming into force 14th June 2022

The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 7(1)(a) and (b), 10(1), 22(1)(a) and 31(1)(a) of the Misuse of Drugs Act 1971f1.

In accordance with section 31(3) of that Act the Secretary of State has consulted the Advisory Council on the Misuse of Drugs.

Annotations to the whole text

Footnotes

f1

1971 c. 38. Section 22 was amended by the Police Reform and Social Responsibility Act 2011 (c. 13), Schedule 17, paragraph 14. See the definition of “prescribed” in section 37(1).

Contents

  1. 1Citation, Commencement and Extent
  2. 2Revocation of the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2021
  3. Signature
  4. Explanatory note

1Citation, Commencement and Extent

(1)

These Regulations may be cited as the Misuse of Drugs (Amendment) (Revocation) (England, Wales and Scotland) Regulations 2022 and come into force on 14th June 2022.

(2)

These Regulations extend to England and Wales and Scotland.

2Revocation of the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2021

The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2021f1 are revoked.

Signature

Kit Malthouse

Minister of State

Home Office

17th May 2022

Explanatory note

(This note is not part of the Regulations)

These Regulations revoke the Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations 2021 (S.I. 2021/1427) (“the 2021 Regulations”).

The 2021 Regulations removed regulation 4B of the Misuse of Drugs Regulations 2001 (“the 2001 Regulations”), that made it lawful to import, export, produce, supply, offer to supply or possess Gamma–butyrolactone (GBL) and 1,4–Butanediol (1,4-BD) in certain circumstances. The 2021 Regulations also added 1,4-Butanediol (1,4-BD) and Gamma-butyrolactone (GBL) to Schedule 1 to the 2001 Regulations. The Schedule in which a controlled drug is placed affects the extent to which the drug can be lawfully imported, exported, produced, supplied or possessed. The controlled drugs placed in Schedule 1 to the 2001 Regulations are those subject to the tightest controls, requiring a Home Office licence in order to access such drugs.

Revocation of the 2021 Regulations means that the exemption in regulation 4B of the 2001 Regulations will remain in force and 1,4-Butanediol (1,4-BD) and Gamma-butyrolactone (GBL) will not be placed in Schedule 1, so a Home Office controlled drugs licence will not be required to lawfully import, export, produce, supply or possess these drugs.

A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or public sector is foreseen.